Table 1.
Variables | Early TRT | Late TRT | P valuea | ||
---|---|---|---|---|---|
No. | % | No. | % | ||
Age (y) | |||||
≤53 | 81 | 60.00 | 25 | 40.32 | .014b |
>53 | 54 | 40.00 | 37 | 59.68 | |
Gender | |||||
Male | 119 | 88.15 | 53 | 85.48 | .647 |
Female | 16 | 11.85 | 9 | 14.52 | |
Smoking | |||||
Current/ever | 99 | 73.33 | 45 | 72.58 | 1.000 |
Never | 36 | 26.67 | 17 | 27.42 | |
Comorbidity score | |||||
=0 | 122 | 84.14 | 50 | 80.65 | .692 |
≥1 | 23 | 15.86 | 12 | 19.35 | |
Chemotherapy regimen | |||||
EP | 117 | 86.67 | 58 | 93.55 | .223 |
Others | 18 | 13.33 | 4 | 6.45 | |
RT fractionation | |||||
Once daily | 35 | 25.93 | 36 | 58.06 | 2.51 × 10−5 b |
Twice daily | 100 | 74.07 | 26 | 41.94 | |
Albumin | |||||
Relatively low | 62 | 45.93 | 34 | 54.84 | .284 |
Relatively high | 73 | 54.07 | 28 | 45.16 |
EP, etoposide‐platinum; RT, radiotherapy; TRT, thoracic radiotherapy.
Log‐rank test.
Statistically significant.